Training future scientists and engineers to improve treatments for neurological disorders
Neural Engineering Training Program (NETP)
The Neural Engineering Training Program is helping future scientists learn how to create better treatments for brain disorders, like epilepsy, by combining engineering and medical knowledge, so they can improve care for patients like you.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10880234 on NIH RePORTER |
What this research studies
The Neural Engineering Training Program (NETP) aims to equip pre-doctoral students with the skills needed to develop innovative treatments for neurological disorders. This program combines engineering principles with clinical practice to address current limitations in therapies, such as unreliable detection of events like epilepsy and inadequate sensory information from devices. By fostering interdisciplinary training, NETP prepares future leaders to tackle challenges in neural engineering and enhance patient care. The program supports four PhD candidates each year, providing them with a diverse curriculum and mentorship opportunities.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with neurological disorders such as epilepsy or those requiring advanced neural prostheses.
Not a fit: Patients with neurological conditions that are not addressed by current engineering approaches may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and reliable treatments for patients with neurological disorders.
How similar studies have performed: Other research in neural engineering has shown promise in improving treatments for neurological disorders, indicating that this approach has the potential for success.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Weiland, James D. — University of Michigan at Ann Arbor
- Study coordinator: Weiland, James D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.